Viewing Study NCT00996567


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-12 @ 10:02 PM
Study NCT ID: NCT00996567
Status: COMPLETED
Last Update Posted: 2017-02-09
First Post: 2009-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Sponsor: University Hospital, Ghent
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant mesothelioma View